4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001179110-11-006920
Sr. VP, Drug Development sold 20,000 shares at an average $5.80 ($116,000)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Koya Keizo Sr. VP, Drug Development | 2011-04-20 | Sale | −10,000 | $5.60 | $56,000 | 29,843 | D: show line 1 in the form |
| Koya Keizo Sr. VP, Drug Development | 2011-04-25 | Sale | −10,000 | $6.00 | $60,000 | 19,843 | D: show line 2 in the form |
| Open-market sales · 20,000 sh · avg $5.80 · $116,000 | |||||||
Loading xslF345X03/edgar.xml…